SLC2A1 and neoplasm: Asgarova et al.[11] have shown that PD‐L1 expression is increased by NF‐κB pathway activation and that tumor hypoxia and inflammation induced by HIF‐1α and GLUT‐1 often mediate tumor progression and cause PD‐L1 elevation.